SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-012499
Filing Date
2023-07-31
Accepted
2023-07-31 06:40:32
Documents
16
Period of Report
2023-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20230731x8k.htm   iXBRL 8-K 36530
2 EX-99.1 imgn-20230731xex99d1.htm EX-99.1 209462
3 GRAPHIC imgn-20230731xex99d1001.jpg GRAPHIC 7018
  Complete submission text file 0001558370-23-012499.txt   484721

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20230731.xsd EX-101.SCH 4365
5 EX-101.DEF imgn-20230731_def.xml EX-101.DEF 3238
6 EX-101.LAB imgn-20230731_lab.xml EX-101.LAB 634
7 EX-101.PRE imgn-20230731_pre.xml EX-101.PRE 10104
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20230731x8k_htm.xml XML 4636
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 231124999
SIC: 2834 Pharmaceutical Preparations